Summary
Antibodies against β1-adrenoceptor can be detected in serum of patients with dilated cardiomyopathy (DCM), which have β-agonist-like activity, and induce a positive chronotropic effect on cardiac myocytes by its persistence at full strength. Effects of the antibodies against β-adrenoceptor from sera of patients with DCM on myocardial cytotoxicity and cytoplasmic free Ca2+-concentration ([Ca2+]i) were observed in the cultured single layer SD rat ventricular cells by using the cytotoxicity assay and fluorescent Ca2+- indicator fura-2/AM. The positive sera of the anti-β-adrenoceptor antibodies from patients with DCM markedly enhanced myocardial [Ca2+]i. Betaloc, a βi-receptor blocker, might inhibit the increase of the antibody-mediated myocardial [Ca2+]i, and the sera from healthy donors had no effect on myocardial [Ca2+]i. Our results suggest that the anti-β-adrenoceptor antibody might increase myocardial [Ca2+]i and result in myocardial damage. The antibodies might activate receptor-gating [Ca2+]-channel, thereby causing myocardial [Ca2+]i rise and calcium overload. Early use of betaloc is recommended in the treatment of dilated cardiomyopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Limas C J, Limas C. Immune-mediated modulation of β-adrenoceptor function in human dilated cardiomyopathy. Clin Immunnol Immunopathol, 1993, 68:204
Wollenberger A, Wallukat G. Anti-β-adrenoceptors auto-antibodies from patients with myocarditis and dilated cardiomyopathy: β-adrenergic agonist activity without desensitization. J Mol Cell Cardiol, 1989, 21(Supp I):67
Wallukat G, Morwinski M, Kowal Ket al. Autoantibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization. Eur Heart J, 1991, 12(Suppl D):178
Rosenbaum M B, Chiale P A, Schejtman Det al. Antibnodies to Betaadrenergic receptors disclosing agonist-like properties in idiopathic dilated cardiomyopathy and Chargas heart disease. J Cardiovasc Electrophysiol, 1994, 5:367
Magnusson Y, Wallukat G, Waagstein Fet al. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the βadrenoceptor with positive chronotropic effect. Circulation, 1994, 89:2760
1994,74:375
ADP/ATP 1995, 11:211
ADP/ATP, 1995, 11:335
Bahouth S W and Malbon C C. Human β-adrenergic receptors: Simultaneous purification of β1 and β2-adrenergic receptor peptides. Biochem J, 1987, 248:557
Kaumann A J. Some aspects of heart beta adrenoceptor function. Cardiovasc Drugs Therapy, 1991, 5:549
Author information
Authors and Affiliations
Additional information
This project was supported by the National Natural Science Fundation of China (No. 39370317).
Rights and permissions
About this article
Cite this article
Yuhua, L., Longxian, C., Yuanshu, T. et al. Mechanism of anti-β-adrenoceptor antibody mediated myocardial damage in dilated cardiomyopathy. Current Medical Science 17, 5–8 (1997). https://doi.org/10.1007/BF02887992
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02887992